Together, these mechanisms prevent the propagation of mutations and other transforming events, as evidenced by the increased rate of spontaneous tumours observed in p53-deficient mice3, the increased frequency of tumourigenesis in Li-Fraumeni patients (harbouring germline mutations of p53)4 and the high frequency of p53 loss-of-function in human cancer5. Here, TP53 is linked to neoplasm.